择期腹主动脉瘤腔内修复术后一个月监测CT扫描的价值有限
该单中心回顾性研究分析了12年间363例择期EVAR患者,评估术后1个月CTA的效用。1个月CTA组316例中检出98例(31%)内漏,仅5例(1.5%)需干预;结论认为对符合器械说明书且术中完成造影无I型内漏的患者,1个月CTA价值有限,6个月开始常规监测是安全的。
要点
- 1个月CTA组316例中检出98例(31%)内漏,仅5例(1.5%)需干预。
- 158例有1个月和3个月CTA的患者中,47例内漏持续,9例新检出,13例消退。
- 47例仅6个月CTA的患者中,16例内漏为完成造影未发现,2例需再干预。
核心结论
- 对符合器械说明书且术中完成造影无I型内漏的择期EVAR患者,1个月监测CTA价值有限。
- 在该患者人群中,6个月开始常规EVAR监测是安全的。
研究设计与样本
- 单中心回顾性病历回顾,纳入12年间在某三级医疗中心接受择期EVAR且有术后监测影像的患者。
- 共363例患者接受择期EVAR并有可用术后影像;排除无术后监测影像者。
主要发现
- 1个月随访CTA组316例中检出98例(31%)内漏,其中5例(1.5%)需干预:1例为髂支内折,4例为I型内漏(3例为说明书外使用患者,1例为术中完成造影Ib型内漏)。
- 158例有1个月和3个月CTA的患者中,47例内漏持续,9例为1个月CTA未发现的新内漏,13例内漏消退;3例(1.2%)因II型内漏和动脉瘤扩张接受干预。
- 47例仅6个月CTA的患者中,16例内漏为完成造影未发现,其中2例接受再干预(1例I型内漏,1例II型内漏)。
临床怎么用
- 作者认为,对符合器械说明书且术中完成造影无I型内漏的择期EVAR患者,1个月监测CTA价值有限,6个月开始常规监测是安全的。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aortic aneurysm repair (EVAR) is the preferred first-line treatment for abdominal aortic aneurysms. Current postprocedure surveillance recommendations by manufacturers are a 1-month computed tomography angiography (CTA) followed by a 12-month CTA in most circumstances. The objective of this study is to determine the utility of the 1-month CTA following elective EVAR and determine if initial surveillance at 6-month CTA is appropriate. METHODS: A single-center retrospective chart review of all elective EVARs at a tertiary medical center over a 12-year period was conducted. Patients were excluded if postoperative surveillance imaging was not available. Data analysis encompassed demographics, chart review, and imaging including angiogram and cross-sectional imaging to asses for endoleaks and other findings. RESULTS: There were 363 patients who underwent elective EVAR and had available postoperative imaging during the study period. Within the 1-month follow-up, a CTA group of 316 patients was detected with 98 (31%) endoleaks. Of these, 5 (1.5%) required intervention: 1 for infolding of an iliac limb and 4 for type I endoleak which was present on completion angiogram-3 in patients treated outside of instructions for use and 1 with a type Ib endoleak on intraoperative completion imaging. In the 158 patients with 1 and 3-month CTAs, there were 47 persistent endoleaks, 9 previously undetected endoleaks not seen in 1-month CTA, and 13 resolved endoleaks. Three patients (1.2%) underwent intervention for type II endoleak and aneurysm expansion. In 47 patients with only a 6-month CTA, there were 16 endoleaks not seen on completion angiography and 2 of which were treated with reintervention-1 for a type I endoleak and 1 for a type II endoleak. CONCLUSIONS: There is limited utility to 1-month surveillance CTA in patients undergoing elective EVAR within the device instructions for use that has no evidence of type I endoleak on completion angiography. It is safe to start routine EVAR surveillance at 6 months in this patient population. This has implications when considering bundled and value-based payments in the longitudinal care of abdominal aortic aneurysm patients.
引用
- Soult MC, Cheng BT, Mansukhani NA, et al. There Is Limited Value in the One Month Post Endovascular Aortic Aneurysm Repair Surveillance Computed Tomography Scan. Ann Vasc Surg. 2018. PMID: 30253190. doi:10.1016/j.avsg.2018.08.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。